Skip to main content
LymeCare Alliance Logo
Send Your Case

Severe Disability in Lyme Disease: Negative ELISA, Positive Western Blot

Share on LinkedIn Facebook

Published on:

Negative ELISA and positive Western Blot results can complicate Lyme disease diagnosis, as seen in this severe disability case. Despite early ELISA results showing no infection, the patient later tested positive on the Western Blot, highlighting the limitations of standard testing and the need for Lyme-literate specialists. This case study sheds light on the diagnostic complexities and challenges faced by patients with advanced Lyme disease symptoms.

Brief Presentation

K.K., a 25-year-old woman from Bulgaria, has endured a progressive and debilitating set of symptoms for over a year, affecting nearly every aspect of her physical and mental well-being. Her symptoms began with fatigue, joint pain, and stiffness, particularly in her elbows, accompanied by persistent headaches, dizziness, and muscle pain. Over time, her symptoms escalated to include night sweats, sleep disturbances, cognitive impairment, heightened sensitivity to light, palpitations, and uncharacteristic pain in her jaw and teeth. She has also experienced unusual skin sensations and increasingly severe neurological symptoms, which have culminated in the loss of use of her legs, leaving her bedridden.

Despite the intensity of her symptoms and the impact on her mobility, K.K.’s concerns have largely been dismissed by medical professionals. Doctors suggested that her symptoms were psychosomatic, further delaying diagnosis and treatment. An MRI scan revealed a small cyst, but her doctors offered no further insights, instead recommending expensive treatment abroad for multiple sclerosis (MS) with no guarantee of improvement. Seeking answers, K.K. took an ELISA test for Lyme disease six months prior, which returned a negative result, leading her doctors to dismiss Lyme disease as a possible diagnosis.

K.K. tried herbal supplements and enzymes to break down potential Borrelia biofilms before taking a Western Blot test. This test, conducted one month later, revealed borderline results for Borrelia spielmanii, a positive marker for Flagellin p41, and a borderline p39 result, suggestive of a potential Borrelia infection. As her condition deteriorates, K.K. has begun urgently seeking Lyme-literate doctors across Europe who can help her, aware that her local medical system may continue to overlook her illness.

Conclusion

K.K.'s case illustrates the challenges faced by patients with Lyme disease or suspected tick-borne infections in regions where diagnostics are limited. The reliance on ELISA tests, which often produce false negatives, and the dismissal of borderline results from more sensitive Western Blot testing have delayed her diagnosis and treatment. Her experience emphasizes the need for broader acceptance of advanced diagnostic methods, a more comprehensive approach to chronic Lyme disease, and a shift in the medical community to take patient-reported symptoms seriously. Without proper intervention, K.K. risks further decline in her already critical condition.

Medical History

  • Initial Symptoms and Diagnostic Efforts: K.K.’s symptoms began over a year ago with fatigue, joint pain (especially in her elbows), and muscle stiffness. She soon developed headaches, dizziness, and muscle pain, along with additional symptoms such as night sweats, cognitive impairments, and severe palpitations.
  • Dismissal by Doctors: Despite the severity of her symptoms, doctors repeatedly suggested that K.K. was imagining her symptoms, disregarding her increasing disability. A neurologist ordered an MRI scan, which showed a small cyst, but no further insights or treatments were provided based on this finding.
  • Negative ELISA Test: Six months prior to seeking alternative diagnostics, K.K. took an ELISA test for Lyme disease, which returned negative results. This led her doctors to dismiss Lyme disease as a potential cause, further delaying her access to appropriate treatment.

Symptoms

  • Musculoskeletal Pain and Stiffness: Persistent pain and stiffness in her joints, particularly in her elbows, which have worsened over time.
  • Severe Neurological Symptoms: K.K. experiences cognitive difficulties, sleep disorders, and dizziness, with recent sensations of being “tied with ropes” around her torso, severe enough to impact her ability to walk.
  • Complete Loss of Leg Function: In the past three weeks, K.K. has lost the use of her legs entirely, leaving her bedridden.
  • Cardiac and Respiratory Symptoms: Frequent palpitations and a strong heartbeat, despite a lack of structural heart issues, as well as episodes of night sweats.
  • Jaw and Teeth Pain: Unexplained pain in her jaw and teeth, despite no dental issues.
  • Skin and Sensory Disturbances: K.K. describes unusual skin sensations and a strange feeling along her spine down to her tailbone.
  • Vision Problems: Sensitivity to light, often accompanied by blurred vision.

Diagnostic Tests

  1. ELISA Test (Six Months Prior): A standard ELISA test was performed, returning a negative result. ELISA is known for its limited sensitivity, particularly in chronic or late-stage Lyme disease cases. False negatives are common, especially in European strains of Borrelia, and this result led to the dismissal of Lyme disease as a possible cause of K.K.'s symptoms.
  2. MRI Scan: An MRI was conducted, revealing a small cyst. However, this finding was not linked to her symptoms, and no further action was taken based on this result.
  3. Western Blot Test (Post-Biofilm Protocol): K.K. undertook a course of herbal products and enzymes aimed at breaking down potential Borrelia biofilms before repeating testing. A Western Blot test conducted afterward showed borderline results for Borrelia spielmanii, along with a positive marker for Flagellin p41 and a borderline p39 result. These findings suggest a possible Borrelia infection, despite the lack of a definitive positive result.

Diagnosis and Treatment Challenges

Despite the Western Blot results indicating borderline markers for Borrelia spielmanii, K.K.’s local healthcare providers remain skeptical of Lyme disease as a diagnosis. The positive markers for p41 and borderline p39 are suggestive of a Borrelia infection but were not considered sufficient for treatment by her doctors, who have dismissed these findings as inconclusive. Instead, they recommended expensive treatment abroad for multiple sclerosis, despite the lack of diagnostic confirmation for MS and no guarantee of symptom improvement.

This lack of recognition of potential Lyme disease has left K.K. without a clear diagnosis or effective treatment plan. In response, she has started looking for Lyme disease specialists in other European countries, aware that her condition may continue to deteriorate without intervention.

Outcomes

  • Loss of Mobility: K.K. has lost the use of her legs, leaving her bedridden and fully dependent on others for care.
  • Dismissal by Local Medical Professionals: The refusal to acknowledge her borderline Western Blot results as potential Lyme disease markers has prevented her from receiving appropriate treatment. This dismissal has compounded her symptoms and left her seeking alternative care abroad.
  • Significant Physical and Psychological Toll: The lack of a diagnosis and the progression of her symptoms have placed a heavy physical and emotional toll on K.K., who fears her condition will continue to decline without proper treatment.

Differential Diagnosis

  • Chronic Lyme Disease and Co-Infections: The borderline markers on the Western Blot test for Borrelia spielmanii, along with positive markers for Flagellin p41 and borderline p39, strongly suggest Lyme disease. Lyme disease, particularly chronic Lyme, can cause a range of symptoms, including musculoskeletal pain, neurological dysfunction, and heart palpitations, all of which align with K.K.’s presentation.
  • Multiple Sclerosis (MS): The neurologist suggested MS as a potential diagnosis based on her neurological symptoms, but this was never confirmed. The offer of expensive treatment for MS abroad came with no guarantee of improvement, indicating that this diagnosis remains speculative.
  • Psychosomatic Disorder: Some doctors suggested K.K.’s symptoms were psychosomatic, but the persistence and progression of her physical symptoms indicate a likely organic cause rather than a psychological origin.

Future Recommendations

  • Immediate Treatment with a Lyme-Literate Specialist: K.K.’s Western Blot results suggest a likely Borrelia infection, and she would benefit from immediate intervention by a Lyme disease specialist who can interpret her test results accurately and recommend an appropriate treatment protocol. Given her severe symptoms and loss of mobility, treatment should ideally begin with antibiotics tailored to Lyme disease, possibly including intravenous options for neurological involvement.
  • Comprehensive Neurological and Infectious Disease Evaluation: Due to her complex symptom profile, K.K. requires a multidisciplinary evaluation, involving both neurologists and infectious disease specialists with experience in tick-borne illnesses. This approach would allow a more thorough exploration of her neurological symptoms while addressing the potential Borrelia infection.
  • Further Testing for Coinfections: In addition to Borrelia, K.K. may have other tick-borne co-infections, such as Babesia or Bartonella, which could explain her severe and diverse symptoms. Comprehensive testing for these infections is recommended to guide a targeted and effective treatment plan.
  • Supportive Therapies for Symptom Management: Due to the chronic and debilitating nature of her symptoms, K.K. would benefit from additional supportive care, including physical therapy, pain management, and counseling to address the psychological toll of her prolonged illness.
  • Patient Advocacy and Education for Healthcare Providers: K.K.’s case underscores the need for better education on Lyme disease diagnostics and a patient-centered approach in Bulgaria. Medical professionals should be educated about the limitations of standard ELISA testing and the importance of recognizing Western Blot results, even when they are borderline.

Discussion

Lyme disease, particularly chronic forms involving European strains such as Borrelia spielmanii, poses significant diagnostic challenges due to the limitations of standard ELISA tests and the lack of recognition for borderline results. In K.K.’s case, the repeated reliance on ELISA testing led to a prolonged delay in diagnosis and treatment, exacerbating her condition. ELISA tests are known for their low sensitivity in chronic Lyme cases, especially for detecting European-specific strains, which often results in false negatives and leads to misdiagnosis or lack of treatment, as seen in K.K.’s experience.

The suggestion of multiple sclerosis, despite a lack of definitive evidence, further reflects the limitations in diagnosing Lyme disease and similar infections. Lyme disease and multiple sclerosis share many overlapping neurological symptoms, making differential diagnosis essential. However, in K.K.’s case, doctors offered only speculative treatment without confirming an MS diagnosis, which could lead to ineffective or even harmful outcomes if Lyme disease is indeed the underlying cause.

K.K.’s borderline results for Borrelia spielmanii, positive p41, and borderline p39 markers should be taken seriously, as these indicate a potential active Borrelia infection. The use of herbal products and enzymes to break down biofilms before testing was a strategic step recommended by Lyme specialists, as biofilms can protect Borrelia bacteria and make them harder to detect. This approach likely contributed to the clearer results on the Western Blot test, suggesting that her infection may have been present but undetected previously.

Broader Implications

K.K.’s case emphasizes the critical need for improved diagnostic protocols and greater acceptance of Lyme disease diagnostics in Bulgaria and similar regions. The over-reliance on ELISA testing and the dismissal of patient-reported symptoms have delayed diagnosis and led to unnecessary suffering for patients like K.K., who now faces significant physical disability. By adopting more sensitive diagnostic tools and recognizing the validity of Western Blot and borderline results, healthcare providers can prevent future cases of delayed diagnosis and provide more timely care.

This case also underscores the importance of Lyme disease education and patient advocacy within the medical community. Doctors need to be aware of the full spectrum of symptoms and presentations associated with Lyme disease and related tick-borne infections. By improving training and encouraging a more open-minded approach to patient symptoms, medical professionals can better support individuals facing complex and underdiagnosed conditions, ultimately leading to better patient outcomes.

This expanded case report provides a detailed examination of K.K.’s symptoms, diagnostic challenges, and the systemic issues that have contributed to her current critical condition. It emphasizes the need for improved Lyme disease awareness and diagnostics, as well as the importance of a multidisciplinary approach for complex cases.

Analysis of K.K.’s Case: The Diagnostic and Treatment Challenges of Suspected Lyme Disease in Bulgaria

K.K., a 25-year-old woman from Bulgaria, has endured a progressively worsening set of debilitating symptoms over the past year, which have severely impacted her physical mobility and quality of life. Despite her extensive symptoms—including joint pain, neurological disturbances, and loss of leg function—her concerns have largely been dismissed by medical professionals, delaying diagnosis and effective treatment. This case illustrates the significant diagnostic and treatment limitations surrounding chronic Lyme disease and tick-borne infections in Bulgaria, and highlights the need for a more patient-centered and evidence-based approach.

Early Diagnostic Missteps and the Limitations of ELISA Testing

K.K.’s symptoms initially presented as fatigue, joint pain, and muscle stiffness, which progressed to include neurological symptoms, night sweats, cognitive impairments, and palpitations. Despite this wide range of symptoms, her concerns were consistently dismissed as psychosomatic by her healthcare providers. A neurologist recommended an MRI scan, which revealed a small cyst, but no follow-up or further explanation was provided. Her condition continued to deteriorate, ultimately resulting in a complete loss of leg function, which has left her bedridden and dependent on others for basic care.

One of the most significant diagnostic missteps in K.K.’s case was the reliance on the ELISA test for Lyme disease, which returned a negative result six months prior. ELISA, while commonly used as a first-line diagnostic tool, is known for its low sensitivity in detecting chronic or late-stage Lyme disease, particularly for European-specific strains like Borrelia spielmanii. False negatives are common in chronic Lyme cases due to low antibody levels or the immune system’s diminished response in long-term infections. The ELISA result led her doctors to dismiss Lyme disease as a possible cause, which significantly delayed her access to appropriate care and allowed her symptoms to worsen.

Importance of Advanced Testing and Biofilm Protocols

In response to her deteriorating condition and the continued dismissal of her symptoms, K.K. sought alternative diagnostic avenues. Based on the recommendation of a LymeCare Alliance member, she tried a regimen of herbal supplements and enzymes aimed at breaking down potential biofilms that could shield Borrelia bacteria, before undergoing a Western Blot test. This test revealed borderline results for Borrelia spielmanii and positive markers for Flagellin p41 and p39, both of which are indicative of a possible Borrelia infection. Biofilms can protect Lyme bacteria from both the immune system and antibiotics, complicating diagnosis and treatment. By addressing biofilms before testing, K.K. likely increased the chance of detecting the infection, yielding clearer results on the Western Blot.

The Western Blot test, which detects specific antibodies against Borrelia proteins, is more sensitive and specific than the ELISA, especially for detecting European strains and chronic infections. Although her results were borderline, the presence of markers for Borrelia spielmanii, along with p41 and p39, strongly suggests an active infection. Unfortunately, her local healthcare providers disregarded these results as inconclusive, recommending costly treatment abroad for multiple sclerosis (MS) without providing any diagnostic confirmation of MS. This insistence on speculative treatment for MS, despite the absence of definitive evidence, reflects a systemic reluctance to recognize the complexity of Lyme disease.

The Physical and Emotional Toll of Diagnostic Dismissal

K.K.’s case exemplifies the profound physical and emotional toll that prolonged diagnostic dismissal can have on patients. The delay in diagnosis and treatment has not only resulted in significant physical deterioration—including the complete loss of mobility—but has also placed immense psychological strain on K.K., as she continues to be dismissed by the medical community. The repeated attribution of her symptoms to psychosomatic causes has left her feeling disregarded and without the support necessary to manage her complex condition.

Patients with chronic Lyme disease frequently face skepticism from healthcare providers, particularly in cases with borderline or ambiguous test results. This dismissive approach often results in prolonged suffering and can push patients to seek alternative treatments at considerable personal expense, as K.K. has done in her search for a Lyme-literate doctor abroad. The lack of support and validation from her healthcare providers has compounded her physical challenges with emotional distress and uncertainty about her future.

Recommendations for Improved Care and Future Steps

  1. Immediate Initiation of Targeted Antibiotic Therapy: Given her Western Blot results indicating possible Borrelia infection, K.K. would benefit from treatment by a Lyme disease specialist who can provide targeted antibiotic therapy. Her severe symptoms, particularly the neurological involvement, may necessitate a combination of oral and intravenous antibiotics.

  2. Comprehensive Neurological and Infectious Disease Assessment: K.K. requires a multidisciplinary evaluation involving neurologists, infectious disease specialists, and potentially rheumatologists. This team can assess her neurological symptoms, cardiac irregularities, and joint pain, while considering the possibility of a complex tick-borne infection.

  3. Further Testing for Coinfections: In cases of chronic Lyme disease, co-infections with other tick-borne pathogens, such as Babesia and Bartonella, are common and often exacerbate symptoms. Additional testing for these co-infections could provide a more complete diagnostic picture and guide more effective, tailored treatment.

  4. Integrated Symptom Management Plan: K.K. would benefit from an integrated care plan that includes physical therapy to help address her mobility issues, pain management, and psychological support to address the emotional impact of her illness. Chronic illness of this nature requires a holistic approach to ensure both physical and mental well-being.

  5. Patient Advocacy and Medical Education: K.K.’s case underscores the need for improved Lyme disease awareness and education for healthcare providers in Bulgaria. Training programs should address the limitations of ELISA testing and recognize the value of Western Blot results, even when borderline, particularly in patients with complex symptoms and chronic conditions.

Broader Implications for Lyme Disease Diagnosis and Management

K.K.’s case highlights systemic issues within Bulgaria’s approach to Lyme disease and tick-borne infections. The reliance on ELISA testing, despite its well-documented limitations, demonstrates a lack of updated protocols and understanding of Lyme disease diagnostics among healthcare providers. Her experience reveals the urgent need for a more comprehensive diagnostic approach that includes Western Blot testing and biofilm consideration in chronic or ambiguous cases.

The overlap of symptoms between Lyme disease and other neurological conditions, such as multiple sclerosis, further complicates diagnosis. However, suggesting treatment for MS without confirmation overlooks the possibility that Lyme disease or a co-infection could be the underlying cause. This tendency to dismiss complex or poorly understood conditions as psychosomatic, especially in the absence of definitive test results, exacerbates patient suffering and delays effective care.

Furthermore, K.K.’s case illustrates the need for patient advocacy and education within the healthcare system. Medical professionals should be trained to recognize the complexity of Lyme disease and the diverse range of symptoms it can present, particularly when European-specific strains and chronic infections are involved.

Conclusion: A Call for Systemic Reform in Lyme Disease Diagnostics

K.K.’s experience is a powerful example of the critical need for reform in Lyme disease diagnostics and treatment protocols in Bulgaria. Her case underscores the importance of using more sensitive diagnostic tools, recognizing borderline results, and taking patient-reported symptoms seriously. The reliance on outdated ELISA testing and the dismissal of potential Lyme disease markers in her Western Blot results have led to a significant delay in care, resulting in severe physical disability and psychological distress.

To prevent similar cases, Bulgaria’s healthcare system must adopt a more inclusive and evidence-based approach to Lyme disease diagnosis and treatment. This includes incorporating advanced diagnostics, such as Western Blot and biofilm consideration, into routine care for patients with chronic symptoms. By prioritizing patient-centered care and increasing awareness of Lyme disease’s complexities, healthcare providers can ensure that patients like K.K. receive timely, accurate, and compassionate treatment.

Latest Case Studies

Latest publications